$10.855
-0.045[-0.41%]
Last update: 2:34PM Get Real Time Here
Roivant Sciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Roivant Sciences using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
06/26/2024 | AM | ROIV | Q4 | -$0.20 | — | — | — | $27.38M | — | — | — | Get Alert |
02/13/2024 | AM | ROIV | Q3 | -$0.49 | -$0.32 | -$0.21 | 34.38% | $17.05M | $32.79M | $37.14M | 13.27% | Get Alert |
11/13/2023 | AM | ROIV | Q2 | -$0.42 | -$0.31 | -$0.40 | -29.03% | $12.53M | $30.12M | $37.10M | 23.19% | Get Alert |
08/14/2023 | AM | ROIV | Q1 | -$0.48 | -$0.30 | -$0.38 | -26.67% | $4.32M | $25.07M | $21.62M | -13.75% | Get Alert |
06/28/2023 | AM | ROIV | Q4 | -$0.39 | -$0.36 | -$0.20 | 44.44% | $9.22M | $21.53M | $27.38M | 27.15% | Get Alert |
02/13/2023 | AM | ROIV | Q3 | -$0.41 | -$0.39 | -$0.49 | -25.64% | $24.34M | $14.64M | $17.05M | 16.48% | Get Alert |
11/14/2022 | AM | ROIV | Q2 | -$0.32 | -$0.41 | -$0.42 | -2.44% | $13.99M | $5.70M | $12.53M | 119.88% | Get Alert |
08/15/2022 | AM | ROIV | Q1 | -$0.13 | -$0.32 | -$0.48 | -50.00% | $7.74M | $7.74M | $4.32M | -44.16% | Get Alert |
06/28/2022 | AM | ROIV | Q4 | -$0.80 | -$0.32 | -$0.39 | -21.88% | $15.15M | $13.35M | $9.22M | -30.91% | Get Alert |
02/14/2022 | AM | ROIV | Q3 | -$0.41 | -$0.25 | -$0.41 | -64.00% | $5.75M | $9.87M | $24.34M | 146.62% | Get Alert |
11/15/2021 | AM | ROIV | Q2 | -$0.06 | -$0.15 | -$0.26 | -73.33% | $1.32M | $6.94M | $13.99M | 101.54% | Get Alert |
09/21/2021 | AM | ROIV | Q1 | -$0.02 | — | -$0.37 | — | $1.58M | — | $7.74M | — | Get Alert |
Roivant Sciences (ROIV) is scheduled to report earnings on June 26, 2024. The last reported earnings were for reported on February 13, 2024 for Q3.
The Actual EPS was $-0.21, which beat the estimate of $-0.32.
The Actual Revenue was $37.1M, which beat the estimate of $32.8M.
Browse earnings estimates, EPS, and revenue on all stocks.